Skip to main content
. Author manuscript; available in PMC: 2019 Mar 18.
Published in final edited form as: J Alzheimers Dis. 2019;67(1):159–167. doi: 10.3233/JAD-180599

Fig. 2.

Fig. 2.

Serum PGRN levels for individual variant carriers relative to median control levels. Circles represent pathogenic and likely pathogenic mutations, squares represent missense variants with uncertain significance and crosses represent benign and likely benign missense variants. The black straight line indicates the median for serum PGRN levels of controls with the 25th and 75th percentiles indicated by the dotted black lines.